In lab cell studies, olive and pomegranate compounds blocked inflammation enzymes and lowered inflammatory chemicals, but this doesn't prove they work in people.
See the scientific wording
In vitro studies demonstrate that olive polyphenols, especially oleocanthal, inhibit cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), reducing prostaglandin production; that hydroxytyrosol and oleuropein inhibit 5-lipoxygenase (5-LOX), lowering leukotriene B4 (LTB4) production; and that pomegranate polyphenols such as punicalagin and urolithin A suppress COX-2 expression and prostaglandin levels in cell-based assays. These laboratory findings indicate that olive and pomegranate compounds can interfere with inflammatory enzyme pathways, but they do not prove anti-inflammatory efficacy in humans. No absolute or relative effect sizes were reported; findings are qualitative in vitro observations.
Indication only — weak evidence
One low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Systematic ReviewReview2026
The review synthesizes in vitro evidence showing direct inhibition of COX and LOX enzymes by specific olive and pomegranate polyphenols, with described mechanisms. This supports the claim of in vitro anti-inflammatory enzyme inhibition, while the review explicitly notes that clinical translation is unproven.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Compounds in olive and pomegranate stick to two enzymes called COX and 5-LOX. These enzymes normally turn a fatty acid into chemical signals that cause pain and swelling. When the compounds block these enzymes, the body makes fewer of those signals. Pomegranate compounds also lower the amount of COX-2 enzyme that cells build, so even less signal is made. This is how these plant compounds interfere with inflammation pathways in lab experiments.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In lab cell studies, olive and pomegranate compounds blocked inflammation enzymes and lowered inflammatory chemicals, but this doesn't prove they work in people.
Mechanism
1 studyOlive and pomegranate contain compounds that block the enzymes COX and LOX. These enzymes make chemical signals that cause pain and swelling. Blocking them means fewer signals are made. This happens in lab dishes, but we do not yet know if eating these fruits changes inflammation in people.
Compounds in olive and pomegranate stick to two enzymes called COX and 5-LOX. These enzymes normally turn a fatty acid into chemical signals that cause pain and swelling. When the compounds block these enzymes, the body makes fewer of those signals. Pomegranate compounds also lower the amount of COX-2 enzyme that cells build, so even less signal is made. This is how these plant compounds interfere with inflammation pathways in lab experiments.
Olive polyphenol oleocanthal binds to the active sites of COX-1 and COX-2 enzymes.
Binding of oleocanthal blocks the conversion of arachidonic acid into prostaglandins by COX-1 and COX-2.
Pomegranate polyphenols punicalagin and urolithin A suppress COX-2 gene expression, reducing the amount of COX-2 enzyme produced.
Lower COX-2 enzyme levels decrease prostaglandin synthesis.
Hydroxytyrosol and oleuropein bind to and inhibit 5-lipoxygenase (5-LOX) in immune cells.
Inhibition of 5-LOX reduces leukotriene B4 synthesis.
Reduced prostaglandin and leukotriene B4 levels decrease inflammatory signaling and immune cell recruitment.
Less supported by current evidence, but not ruled out
Pomegranate compounds also act as antioxidants. They soak up reactive oxygen molecules that would otherwise trigger the LOX enzyme. With less trigger, the LOX enzyme is less active, so fewer leukotriene signals are made. This is a second way pomegranate compounds reduce inflammation signals.
Pomegranate polyphenols scavenge reactive oxygen species.
Reduced oxidative stress lowers activation of LOX enzymes.
Decreased LOX activity reduces leukotriene formation.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Human Trials on Olive and Pomegranate Polyphenols and Inflammatory Enzyme Markers
Systematic search and meta-analysis of randomized controlled trials in healthy adults or adults with inflammatory conditions; interventions: oral olive or pomegranate polyphenol extracts or foods; comparator: placebo or low-polyphenol diet; outcomes: COX-1/COX-2 activity, 5-LOX, prostaglandins, LTB4, and clinical inflammation markers; duration: at least 4-12 weeks.
Double-Blind RCT of Oleocanthal-Rich Olive Polyphenols vs Placebo on COX and 5-LOX Pathways
Randomized, double-blind, placebo-controlled trial in adults; intervention: standardized oleocanthal-rich olive polyphenol extract; comparator: placebo; outcomes: COX-1/COX-2 activity, prostaglandin E2, 5-LOX, LTB4 in blood or relevant tissues; duration: 8-12 weeks.
Prospective Cohort of Dietary Olive and Pomegranate Polyphenol Intake and Inflammatory Enzyme Markers
Prospective cohort of adults; exposure: validated dietary intake of olive/pomegranate polyphenols; comparator: low intake; outcomes: incident inflammatory conditions or repeated measures of COX/LOX markers; follow-up: at least 1 year.
Cross-Sectional Comparison of Polyphenol Biomarkers and Inflammatory Enzyme Activity
Cross-sectional study measuring urinary or plasma polyphenol metabolites and inflammatory enzyme markers (COX-1/2, 5-LOX, prostaglandins, LTB4) in adults with varying olive/pomegranate intake.
Cell-Based Assay of Olive and Pomegranate Polyphenols on COX-1/COX-2 and 5-LOX Pathways
In vitro assays using macrophage, monocyte, or chondrocyte cell lines or primary cells stimulated with LPS or inflammatory cytokines; interventions: purified polyphenols at multiple concentrations; comparator: vehicle control and reference inhibitors; outcomes: COX-1/COX-2 activity/expression, 5-LOX activity, prostaglandin E2, LTB4; duration: hours to 48 hours.